F-02-2-Na

N/A

Report date: 2026/02/18 20:02:09
NME

Base Information

Drug NameF-02-2-Na
Drug Alias NameF-02-2-NaF022Na
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Hengqin Novagains Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangdong Hengqin Novagains Biopharmaceutical Co LtdGuangzhou Xinchuangyi Biomedical Co LtdWelman (Xiang Bei) Pharmaceuticals Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHyperuricemiaGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A